Charles River Laboratories International, Inc. (CRL) vs Twist Bioscience Corporation (TWST)
- Charles River Laboratories International, Inc. CRL 299.77 −2.11%
- Twist Bioscience Corporation TWST 132.75 −8.13%
Charles River Laboratories International, Inc. and Twist Bioscience Corporation are both Diagnostics & Research companies. Charles River Laboratories International, Inc. is the larger, with a market value of $14.6B against $9.5B — 1.5× the size. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against −0.74%. Charles River Laboratories International, Inc. has the higher net margin (−5.96% vs −31.7%) and the higher return on invested capital (1.07% vs −30.8%). Across the 18 metrics below, Charles River Laboratories International, Inc. leads on 11 and Twist Bioscience Corporation on 7.
Valuation
Profitability
| Metric | CRL | TWST | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 32.67% | 51.97% | 50.89% |
| Operating margin | 2.25% | (33.58%) | (8.57%) |
| Net margin | (5.96%) | (31.66%) | (6.37%) |
| Free cash flow margin | 9.27% | (22.15%) | 0.00% |
| Return on equity | (7.69%) | (29.59%) | (2.92%) |
| Return on assets | (3.16%) | (20.78%) | (6.71%) |
| Return on invested capital | 1.07% | (30.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack